EnyanjulaRetatrutid, eddagala eppya erya triple-agonist mu kiseera kino eri mu kunoonyereza mu bujjanjabi, lireeta obwagazi obw’amaanyi olw’obusobozi bwalyo okukyusa mu kuddukanya obuzito n’obujjanjabi bwa sukaali obw’ekika eky’okubiri. Soma Ebisingawo

EnyanjulaOkulinnya kw’eddagala eppya eriweweeza ku mugejjo kuleeseewo okukubaganya ebirowoozo okugenda mu maaso: ddala eby’okugonjoola eddagala bisobola okudda mu kifo ky’enkyukakyuka mu bulamu obw’ekinnansi ng’endya n’okukola dduyiro? Soma Ebisingawo

EnyanjulaEkirwadde ky’omugejjo mu nsi yonna kyeyongera, era eby’okugonjoola eby’ennono —endya, dduyiro, n’okulongoosa omugejjo —bifubye okuvaamu ebivaamu ebiyinza okulinnyisibwa, eby’ekiseera ekiwanvu. Soma Ebisingawo

EnyanjulaRetatrutid ddagala lya mulembe oguddako erinoonyereza era nga lifunye okufaayo okunene olw’obusobozi bwalyo mu kujjanjaba omugejjo ne sukaali ow’ekika eky’okubiri. Soma Ebisingawo

EnyanjulaOmugejjo gukyagenda mu maaso okuba ekimu ku kusoomoozebwa kw’ebyobulamu okusinga obukulu mu nsi yonna, nga kukwatagana n’embeera ezitawona nga sukaali, endwadde z’emisuwa n’emisuwa, ne kookolo omu. Soma Ebisingawo

EnyanjulaEnsi y’eddagala ly’okugejja ekyuka mangu, ekiwa essuubi eri abantu abalwanagana n’omugejjo n’embeera z’enkyukakyuka y’emmere ezikwatagana nabyo. Eddagala ssatu lifunye okufaayo okunene: Retatrutid, Semaglutid (Ozempic/Wegovy), ne Tirzepatid (Mounjaro/Zepbound). Soma Ebisingawo

EnyanjulaMu myaka egiyise, emboozi y’ensi yonna ku kuddukanya omugejjo n’okujjanjaba omugejjo ekyuse nnyo. Sayansi w’obusawo abadde asika ensalo z’ebyo ebisoboka, ng’asukka amagezi ku ngeri y’obulamu n’eddagala erisookerwako okutuuka ku bujjanjabi obw’omulembe, obugendereddwamu ebintu bingi. Soma Ebisingawo

Eddagala lya GLP-1 omuli eddagala nga semaglutide ne liraglutide, kibiina kya ddagala erikoppa obusimu obw’obutonde obwa GLP-1 okutereeza ssukaali mu musaayi n’okuddukanya okwagala okulya. Eddagala lino likola nnyo mu kujjanjaba ssukaali ow’ekika eky’okubiri nga liyamba okufulumya insulini, liziyiza okufulumya glucagon, n’okulongoosa okufuga glucose mu musaayi okutwalira awamu. Era zikkirizibwa ekitongole kya FDA okugejja mu kuddukanya omugejjo, nga ziyamba abalwadde okukendeeza enjala n’okutumbula okukendeeza amasavu. Wadde okutwalira awamu tezirina bulabe, ziyinza okuleeta ebizibu ebimu ng’okutabuka mu lubuto. Olw’okukosa ennyo obulamu bw’enkyukakyuka mu mubiri, GLP-1 receptor agonists kye kimu ku bikozesebwa ebikulu mu bujjanjabi bwa sukaali n’omugejjo ogw’omulembe guno. Soma Ebisingawo

GLP-1 receptor agonists, nga semaglutide, liraglutide, ne exenatide, ddagala ddungi erikendeeza ku buzito. Semaglutid yeeyoleka olw’engeri gy’ekwata ennyo ku kukendeeza ku buzito bw’omubiri, ng’abalwadde bakendeeza ku buzito bw’omubiri obutuuka ku bitundu 15% mu kugezesebwa mu malwaliro. Liraglutide nayo eraga ebisuubiza ebivaamu, wadde ng’ebikolwa byayo biba bitono nnyo. Exenatide ne dulaglutide, wadde nga za mugaso, ziwa ebiva mu kugejja eby’ekigero. Okulonda eddagala ettuufu erya GLP-1 kisinziira ku biruubirirwa by’omuntu kinnoomu, ebyafaayo by’obujjanjabi, n’okugumiikiriza ebizibu ebivaamu, ng’okunoonyereza okugenda mu maaso kusuubiza obujjanjabi obw’omulembe n’okusingawo mu biseera eby’omu maaso. Soma Ebisingawo